A Medical Research and Evaluation Facility (MREF) and Studies Supporting the Medical Chemical Defense Program. Determination of the Minimum Effective Pyridostigmine Pretreatment Dose in Monkeys Challenged with 5 X LD50 Soman and Treated with Atropine/2-Pam.
Abstract
This task was conducted to determine the minimum dose of pyridostigmine (PYR), and the associated level of erythrocyte acetycholinesterase inhibition (AChE-I), that provides protection from 5 X 48-br GD LD50 of untreated monkeys. Monkeys were injected im with GD and treated with 0.4 mg atropine (ATR) free base and 25.7 mg pralidoxime (2-PAM) per kg BW.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 1995
- Accession Number
- ADA299787
Entities
People
- Carl T. Olson
- M. C. Matthews
- Robyn C. Kiser
- Ronald G. Menton
- Timothy L. Hayes
Organizations
- Battelle Memorial Institute